Loading organizations...

§ Private Profile · Paris, France
AI agents for healthcare admin
Parallel has raised $208.5M across 5 funding rounds.
Key people at Parallel.
Parallel was founded in 2024 by Yubo Ruan (Founder) and Paul Lafforgue (Founder) and Thomas Sohet (Founder).
Parallel has raised $208.5M in total across 5 funding rounds.
We build AI agents that automate healthcare admin workflows. Our agents navigate legacy hospital software like humans (using mouse and keyboard) and automate end-to-end workflows (starting with medical coding), freeing medical professionals from manual tasks.
Key people at Parallel.
Parallel is a French startup founded in 2024 that develops AI-driven automation tools specifically for healthcare administration, focusing initially on medical coding. Its AI agents navigate legacy hospital software like humans, automating repetitive, time-consuming tasks without requiring costly system integrations. This approach improves operational efficiency, reduces errors, and frees healthcare professionals to focus more on patient care rather than paperwork. Parallel serves hospitals and healthcare providers by streamlining complex administrative workflows through generative AI, leveraging large language models to handle unstructured clinical data accurately[1][2][3][4].
For an investment firm, Parallel represents a mission-driven company aiming to reduce administrative burdens in healthcare through cutting-edge AI, aligning with investment philosophies that prioritize vertical AI applications with high impact. The startup operates in the healthcare and AI sectors, contributing to the ecosystem by pioneering practical AI adoption in a traditionally slow-to-automate industry, thus accelerating digital transformation in healthcare administration[1][4].
Parallel was founded in 2024 by Paul Lafforgue and Thomas Sohet in Paris, France. Paul, with a background from Ecole Polytechnique and HEC and experience at Meta and McKinsey, brings deep AI expertise and industry insight. Thomas, former CTO of Yago.be, contributes strong technical leadership and startup scaling experience. The idea emerged from recognizing the persistent administrative inefficiencies in hospitals caused by fragmented software and manual workflows. Early traction included rapid development of AI agents capable of navigating hospital software and automating medical coding within just three months, validated by endorsements from healthcare professionals[1][2][3][4].
Parallel rides the wave of AI-driven automation in healthcare, a sector historically burdened by outdated software and manual administrative tasks. The timing is critical as hospitals increasingly seek solutions to reduce administrative overhead while maintaining compliance and accuracy. Market forces such as rising healthcare costs, staff shortages, and the push for digital transformation favor AI solutions that can integrate with legacy systems without disruption. Parallel’s approach exemplifies a broader trend toward vertical AI agents that specialize in domain-specific workflows, setting a precedent for scalable AI adoption in complex industries[1][4].
Parallel is poised to expand its engineering team and accelerate deployments across hospitals, with plans to develop AI agents targeting additional administrative pain points beyond medical coding. Future trends shaping its journey include advances in generative AI, increasing demand for healthcare efficiency, and regulatory pressures to improve data accuracy and compliance. As Parallel scales, its influence could extend beyond healthcare administration, potentially inspiring similar AI-driven automation models in other complex, legacy-software-dependent sectors. Its success will hinge on continued innovation, adoption by healthcare providers, and the ability to demonstrate measurable improvements in operational efficiency[1][4].
This positions Parallel as a promising leader in transforming healthcare administration through AI, addressing a critical bottleneck in the healthcare system while enabling medical professionals to focus on patient care.
Parallel was founded in 2024 by Yubo Ruan (Founder) and Paul Lafforgue (Founder) and Thomas Sohet (Founder).
Parallel has raised $208.5M in total across 5 funding rounds.
Parallel's investors include Julia Andre, Arthur Mensch, Felix Blossier, Quentin de Metz, Vincent Bouvier, eFounders, Pierre Entremont, Y Combinator, Index Ventures, Mamoon Hamid, Spark Capital, First Round Capital.
Parallel has raised $208.5M across 5 funding rounds. Most recently, it raised $20.0M Series A in March 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 1, 2023 | Earlybird | Seed | IDEO Ventures | Alumni Ventures, Fiat Ventures, Goodwater Capital, Lightspeed Venture Partners, David Beazley, Rarebreed Ventures, ResilienceVC, Seven Seven SIX, Sweater Ventures, Wintrust Bank |
| May 16, 2022 | Satori | $10.0M Seed | Blockchange Ventures, Polychain Capital | Gavin Wood, Acala, A Capital, Clover, Coinbase Ventures, Jump Crypto, Portal Innovations |
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 19, 2026 | $20M Series A | Julia Andre | Arthur Mensch, Felix Blossier, Quentin DE Metz, Vincent Bouvier, EFounders, Pierre Entremont, Y Combinator | Announced |
| Nov 14, 2025 | $100M Series A | Index Ventures, Mamoon Hamid | Spark Capital, First Round Capital, Vinod Khosla, Terrain | Announced |
| Apr 3, 2025 | $3.5M Seed | Pierre Entremont | Better Angle, Bpifrance, Kima Ventures, Y Combinator | Announced |
| Mar 1, 2024 | $35M Series U | — | Animoca Brands, CMCC Global, Infinity Ventures Crypto, M13, Solana Ventures, Union Square Ventures, Aleksander Leonard Larsen, Balaji Srinivasan, 白川亜祐旭, 中馬 和彦, 田口 順一, Daisuke Miyoshi, Resona Capital, Shizuoka Capital, Yamaguchi Capital | Announced |
| Oct 1, 2021 | $50M Series A | — | Andreessen Horowitz, Paradigm, Ribbit Capital, Tiger Global Management, Kunal Shah | Announced |